211
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Agmatine ameliorates acetic acid-induced colitis in rats: involvement of nitrergic system

, , , , , & show all
Pages 242-249 | Received 05 Dec 2018, Accepted 02 Feb 2019, Published online: 01 Mar 2019

References

  • Yasukawa K, Tokuda H, Tun X, et al. The detrimental effect of nitric oxide on tissue is associated with inflammatory events in the vascular endothelium and neutrophils in mice with dextran sodium sulfate-induced colitis. Free Rad Res. 2012;46:1427–1436.
  • Rezayat SM, Dehpour A-R, Motamed SM, et al. Foeniculum vulgare essential oil ameliorates acetic acid-induced colitis in rats through the inhibition of NF-kB pathway. Inflammopharmacol. 2018;26:851–859.
  • Khalili H, Chan SSM, Lochhead P, et al. The role of diet in the aetiopathogenesis of inflammatory bowel disease. Nature Rev Gastroenterol Hepatol. 2018;15(9):1.
  • Kankuri E, Vaali K, Knowles RG, et al. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl) benzyl] acetamidine. J Pharmacol Exp Ther. 2001;298:1128–1132.
  • Vento P, Kiviluoto T, Järvinen HJ, et al. Changes in distribution of three isoforms of nitric oxide synthase in ulcerative colitis. Scand J Gastroenterol. 2001;36:180–189.
  • Moncada S, Palmer R, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109–142.
  • Miller MJ, Sandoval M. III. A molecular prelude to intestinal inflammation. Am J Physiol Gastroint Liver Physiol. 1999;276:G795–G799.
  • Lefer AM, Lefer DJ. II. Nitric oxide protects in intestinal inflammation. Am J Physiol Gastroint Liver Physiol. 1999;276:G572–G575.
  • Zingarelli B, Cuzzocrea S, Szabó C, et al. Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther. 1998;287:1048–1055.
  • Nakamura H, Tsukada H, Oya M, et al. Aminoguanidine has both an anti-inflammatory effect on experimental colitis and a proliferative effect on colonic mucosal cells. Scand J Gastroenterol. 1999;34:1117–1122.
  • Blanchard HS, Dernis-Labous E, Lamarque D, et al. Inducible nitric oxide synthase attenuates chronic colitis in human histocompatibility antigen HLA-B27/human beta2 microglobulin transgenic rats. Eur Cyt Network. 2001;12:111–118.
  • Hong S, Lee J, Kim C, et al. Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC Neurosci. 2007;8:81.
  • Sharawy MH, Abdelrahman RS, El-Kashef DH. Agmatine attenuates rhabdomyolysis-induced acute kidney injury in rats in a dose dependent manner. Life Sci. 2018;208:79–86.
  • Uzbay TI. The pharmacological importance of agmatine in the brain. Neurosci Biobehav Rev. 2012;36:502–519.
  • Li X, Liu Z, Jin H, et al. Agmatine protects against zymosan-induced acute lung injury in mice by inhibiting NF-κB-mediated inflammatory response. BioMed Res Int. 2014;2014:1.
  • Rashidian A, Roohi P, Mehrzadi S, et al. Protective effect of Ocimum basilicum essential oil against acetic acid–induced colitis in rats. J Evid Based Complementary Altern Med. 2016;21:NP36–NP42.
  • Deshmukh C, Veeresh B, Pawar A. Protective effect of Emblica officinalis fruit extract on acetic acid induced colitis in rats. J Herb Med Toxicol. 2010;4:83–87.
  • Rashidian A, Muhammadnejad A, Dehpour A-R, et al. Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway. Inflammopharmacol. 2016;24:109–118.
  • Khan I, Oriowo MA, Anim JT. Amelioration of experimental colitis by Na-H exchanger-1 inhibitor amiloride is associated with reversal of IL-1β and ERK mitogen-activated protein kinase. Scand J Gastroenterol. 2005;40:578–585.
  • Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206–209.
  • Allred DC, Harvey JM, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11:155–168.
  • Hartmann RM, Morgan Martins MI, Tieppo J, et al. Effect of Boswellia serrata on antioxidant status in an experimental model of colitis rats induced by acetic acid. Dig Dis Sci. 2012;57:2038–2044.
  • Jurjus AR, Khoury NN, Reimund J-M. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods. 2004;50:81–92.
  • Gonzalez R, Rodriguez S, Romay C, et al. Anti-inflammatory activity of phycocyanin extract in acetic acid-induced colitis in rats. Pharmacol Res. 1999;39:55–59.
  • Sharon P, Stenson WF. Metabolism of arachidonic acid in acetic acid colitis in rats: similarity to human inflammatory bowel disease. Gastroenterology. 1985;88:55–63.
  • Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3:521.
  • Dionne S, Hiscott J, D'Agata I, et al. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies . Dig Dis Sci. 1997;42:1557–1566.
  • Ordás I, Mould DR, Feagan BG, et al. Anti‐TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics‐based dosing paradigms. Clin Pharmacol Ther. 2012;91:635–646.
  • Hong S, Park K, Kim CY, et al. Agmatine inhibits hypoxia-induced TNF-alpha release from cultured retinal ganglion cells. Biocell. 2008;32:201–205.
  • Hong S, Kim CY, Lee JE, et al. Agmatine protects cultured retinal ganglion cells from tumor necrosis factor-alpha-induced apoptosis. Life Sci. 2009;84:28–32.
  • Singer II, Kawka DW, Scott S, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 1996;111:871–885.
  • Rachmilewitz D, Stamler JS, Bachwich D, et al. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut. 1995;36:718–723.
  • Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology. 2004;113:427–437.
  • Guslandi M. Nitric oxide and inflammatory bowel diseases. Eur J Clin Invest. 1998;28:904–907.
  • McCafferty DM, Mudgett JS, Swain MG, et al. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology. 1997;112:1022–1027.
  • Pfeiffer C, Qiu B. Effects of chronic nitric oxide synthase inhibition on TNB‐induced colitis in rats. J Pharm Pharmacol. 1995;47:827–832.
  • Camuesco D, Comalada M, Rodríguez-Cabezas ME, et al. The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br J Pharmacol. 2004;143:908–918.
  • Venkataranganna M, et al. NCB-02 (standardized Curcumin preparation) protects dinitrochlorobenzene-induced colitis through down-regulation of NFκ-B and iNOS. World J Gastroenterol. 2007;13:1103.
  • Dong W-G, Mei Q, Yu J-P, et al. Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis. World J Gastroenterol. 2003;9:1307.
  • El-Kashef DH, El-Kenawi AE, Rahim MA, et al. Agmatine improves renal function in gentamicin-induced nephrotoxicity in rats. Can J Physiol Pharmacol. 2016;94:278–286.
  • Abe K, Abe Y, Saito H. Agmatine suppresses nitric oxide production in microglia. Brain Res. 2000;872:141–148.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.